Navigation Links
DrugDev Invites Pharmaceutical Companies to Support “George’s RunforType1” 100km (62 miles) on 30 September in London to End Type 1 Diabetes in Children

Clinical operations technology innovator DrugDev is joining forces with award-winning UK playwright and author Simon Vinnicombe and the type 1 diabetes charity JDRF to raise funds and awareness and help cure Type 1 diabetes. DrugDev is inviting pharmaceutical companies to sponsor and participate in two September events:

  •     Case Study: Fighting Type 1 Diabetes – George’s Story – an inspirational webinar on 13 September about Simon’s son George’s battle with Type 1 and progress in finding a cure
  •     “George’s RunforType1” – a 100km Simon will run in London 30 September (six years to the day after George was diagnosed) to raise funds for Type 1 research.

Join in the efforts to fund research for Type 1 diabetes by supporting George's RunforType1 and the webinar with your corporate sponsorship, or for individual donations visit George’s RunforType1.

Who is George Vinnicombe? Watch a heartwarming video of Simon and his son to learn why this topic is so important to families worldwide. Then read below for details on how to get involved.

(Webinar) Case Study: Fighting Type 1 Diabetes – George’s Story
Date: 13 September 2017
Time: 10:00-10:45 am ET
Register here
The webinar is complimentary

According to JDRF over 400,000 people in the UK have Type 1 diabetes, and more than 29,000 are children. In this webinar hosted by DrugDev, you’ll learn about:

  •     The impact of Type 1 diabetes on one family and the incredible diligence required in caring for an insulin-sensitive Type 1 child
  •     Developments in technology and medicine in the six years since George’s diagnosis and the journey towards a possible cure for Type 1 diabetes

George was six months old when he was sent to Accident and Emergency with a chest infection. Simon Vinnicombe will discuss the developments in technology and medicine in the six years since George’s diagnosis and the journey towards a possible cure for Type 1 diabetes. Join us for the story of a remarkable and courageous young boy who taught his family to never give up, and reminds all of us in the pharma and biotech world why we do what we do.

George’s RunForType1 100km
Date: 30 September 2017
Time: 5:30am BST to 4pm BST
Location: Ham Gate Avenue, Richmond Park, London TW105

“For George and everyone suffering from Type 1 diabetes, I’m asking for your help,” explained Simon Vinnicombe. “I’m going to run 100km in a day – the equivalent of 62 miles – something way beyond my limits. It will almost certainly break me, both physically and emotionally, but I won’t give up. I couldn’t think of anything more fitting. It’s a daily battle of endurance caring for a child with Type 1 diabetes, and I hope people will get a glimpse of just how much a cure would mean to me and thousands of parents and children the world over.”

Vinnicombe continued, “I also believe that a cure is close. I am utterly sure that brilliant people are doing brilliant work which will eventually end this condition. But they need the money for research. I’m asking you to support George and all children with Type 1 diabetes, and together we can bring that cure a step closer.”

“On a personal as well as professional level, I could not be more humbled and proud to support Simon in this tremendous endeavor to raise funds and awareness in support of children around the world like George who are suffering with Type 1 Diabetes,” said Ibs Mahmood, DrugDev President and CEO. “Awareness is great, but we need to raise funds so heroic organizations such as JDRF can continue to research new solutions to end this terrible disease once and for all. Any amount is welcome from individuals, and we have developed some exciting sponsorship opportunities for pharmaceutical companies. I am honored to have known Simon for many years, and I am certain he will do the impossible and succeed in this 100km run using his son George’s courage as inspiration to keep running forward.”

About DrugDev

DrugDev, a QuintilesIMS company, helps the world do more trials through industry-wide collaboration, standardization and a beautiful technology experience. DrugDev Spark™, the unified clinical operations suite, is comprised of proven solutions used by 85 sponsors and CROs on nearly 2,000 clinical trials to transform the quality and efficiency of clinical trials from startup through closeout. DrugDev Spark is powered by the DrugDev Golden Number, the award-winning universal identifier for global site facilities and investigators used by TransCelerate and the Investigator Databank. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs trust DrugDev by scheduling a demo of DrugDev Spark at

Read the full story at

Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugDev President of Patient Solutions Eric Delente Named One of the PharmaVOICE 100 Most Influential Professionals in Life Sciences
2. New DrugDev Educational Webinar Outlines Best Practices in Outsourcing Site Payments for Pharma and Biotech
3. DrugDev to Showcase Award-Winning Clinical Trial Operations Technology at the DIA 53rd Annual Meeting
4. DrugDev Thought Leaders Share Experience and Insights on How Transformative Technology Improves Clinical Trials at Premier Pharma and Biotech Industry Conferences in Q2
5. New DrugDev Educational Webinar Reveals How Biotechs and Smaller Pharmaceutical Companies Gain Site Attention and Engagement by Optimizing Clinical Trial Payments
6. New Webinar Introduces DrugDev Spark™, First Unified Clinical Operations Suite, with Proven Solutions Including Site Selection, Activation, Payments, Engagement, eConsent
7. DrugDev Spark™ Introduced as the First Comprehensive Unified Suite of Proven Solutions for Clinical Operations
8. New DrugDev Educational Webinar Shows Pharma How to Put the “Informed" Back Into Patient Consent for Global Clinical Studies with Groundbreaking Mobile Solution
9. Leading Clinical Trial Technology Innovator DrugDev Achieves EU-U.S. Privacy Shield Certification
10. DrugDev Adds the Definitive eConsent Mobile Solution to Its Unified Clinical Operations Suite with Acquisition of Pioneering Market Leader SecureConsent
11. Learn How DrugDev has Become the Fastest Growing Clinical Trials Technology Company by Transforming Site Selection, Activation, Payments, and Engagement at New Webinar
Post Your Comments:
(Date:10/12/2017)... ... 12, 2017 , ... First Healthcare Compliance (FHC), an industry ... a range of technology and learning solutions at the 68th Annual American Healthcare ... be held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
(Date:10/12/2017)... ... 12, 2017 , ... HMP , a leader in healthcare events and ... Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie ... annual award competition recognizes editorial and design excellence across a range of sectors. This ...
(Date:10/12/2017)... GRAND RAPIDS, Mich. (PRWEB) , ... October 12, ... ... OnSite Wellness, has been named one of Michigan’s 2017 Best and Brightest in ... Best and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- The Rebound mobile app is poised to become a ... of prescription drug addiction. The app empowers users to develop ... down their dosage in a safe, controlled manner while maximizing ... first 100,000 people to sign up will enjoy 3 months ... ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/19/2017)... a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed ...   ... Jim Bertolina, ... Tom Tefft ... medical device executive Josh Stopek , PhD, who has led R&D and business development ...
Breaking Medicine Technology: